Med Discovery SA - The Onco-Urology Company

Management

David Deperthes, Ph.D – Chief Executive Officer
Founder and CEO of Med Discovery, Dr. Deperthes won the NETS’ Prize in 2003 which consists in an intensive business and management training dispensed at Babson’s college in Boston to a young entrepreneur selected by the NETS’ prize committee. More recently, he has participated in the IMD Start-up competition and got the opportunity to work with executive MBA students.

Christoph Kündig, Ph.D – Director Research & Development
Dr. Kündig obtained his Ph.D in life sciences at Swiss Institute of Technology of Zurich, Switzerland. He has joined Professor Marc Ouellette's laboratory at Laval University (Québec, Canada) in 1994 as post-doctoral fellow. He worked in molecular biology of Leishmaniose. He then joined Essential Therapeutics Company at Montain View in California as Sr. Research Scientist. Med Discovery hired Dr. Kündig as R&D Director at the beginning of its R&D activity.

Tom Gibbs, Ph.D - Director of Operations
Tom Gibbs has spent the last 12 years in the life-science technology supplies industry in the US and in Switzerland. He has held positions of increasing responsibility first at Molecular Devices Corporation (California, USA), then at Cytion SA (Lausanne), and most recently as Head of Marketing and Customer Support at Covalys Biosciences AG (Basel). In these companies he was involved in development, applications, support, and strategic and tactical marketing of complex instrumentation- and consumable- based technologies for the life science research and pharmaceutical industries.

Prior to this, Dr. Gibbs worked for six years in a biopharmaceutical company, Delta Biotechnology in the UK where he was in charge of developing molecular biology quality assurance strategies and methods. Tom holds a PhD in microbial genetics.